Komori
Tri Chemical Laboratories (4369) · FactHigher Equity-Method Investment Income for the First Half

Increase in Investments in Affiliates and Equity-Method Investment Losses

First written in FY2018-Q3. 2 of 34 entries say "Restated". Latest entry: FY2027-H1.

34entries
10years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q3 – FY2026-H12017: 12018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 42026
Same theme, other companies
Recognition of Equity-Method Investment LossesA theme 87 companies write about · 87 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2023: 19 of 68 companies on the "Worse" side.

24 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 87 companies compared. The sentences above are computed from all 87.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Higher Equity-Method Investment Income for the First HalfAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 619,156 648,397」

    Equity in earnings of affiliates accounted for using the equity method for the interim consolidated accounting period amounted to ¥648.397 million, up from ¥619.156 million in the same period of the previous year.
  3. FY2026AdvancedAnnual report

    「Number of affiliates accounted for using the equity method: 3 companies Names of companies accounted for using the equity method: SK Tri Chem Co., Ltd.　株式会社エッチ・ビー・アール　安徳拓化 (安徽) 電子材料有限公司 安徳拓化 (安徽) 電子材料有限公司 has been included in the scope of equity-method accounting because the Company made a new investment in it during the current consolidated fiscal year.」

    The Company invested ¥718.080 million in 安徳拓化（安徽）電子材料有限公司 in China and added the new Chinese joint venture to its equity-method affiliates.
  4. FY2026-H1Interim-period decrease in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 768,250 619,156」

    Equity in earnings of affiliates accounted for using the equity method for the interim consolidated accounting period amounted to ¥619.156 million, down from ¥768.250 million in the same period of the previous year.
  5. FY2025Increase in full-year equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method amounted to ¥1,309.648 million.」

    Equity in earnings of affiliates accounted for using the equity method increased from ¥1,036.987 million in the previous fiscal year to ¥1,309.648 million. Pretax net income for the period at SK Tri Chem Co., Ltd. also increased from ¥3,863.668 million to ¥4,828.098 million.
  6. FY2025-H1Higher Equity-Method Investment Income for the First HalfAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 649,790 768,250」

    Equity in earnings of affiliates accounted for using the equity method for the interim consolidated accounting period amounted to ¥768.250 million, up from ¥649.790 million in the same period of the previous year.
  7. FY2025-Q1First-quarter decrease in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 389,517 317,915」

    Equity in earnings of affiliates accounted for using the equity method for the first quarter of the cumulative consolidated period amounted to ¥317.915 million, down from ¥389.517 million in the same period of the previous year.
  8. FY2024Full-year decrease in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 2,409,980 1,036,987」

    Equity in earnings of affiliates accounted for using the equity method decreased from ¥2,409.980 million in the previous fiscal year to ¥1,036.987 million.
  9. FY2024-Q3Third-quarter decrease in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 2,059,730 809,846」

    Equity in earnings of affiliates accounted for using the equity method for the third quarter of the cumulative consolidated period amounted to ¥809.846 million, down from ¥2,059.730 million in the same period of the previous year.
  10. FY2024-Q2Second-quarter decrease in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 1,177,698 649,790」

    Equity in earnings of affiliates accounted for using the equity method for the second quarter of the cumulative consolidated period amounted to ¥649.790 million, down from ¥1,177.698 million in the same period of the previous year.
  11. FY2024-Q1First-quarter decrease in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 449,956 389,517」

    Equity in earnings of affiliates accounted for using the equity method for the first quarter of the cumulative consolidated period amounted to ¥389.517 million, down from ¥449.956 million in the same period of the previous year.
  12. FY2023Increase in full-year equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method amounted to ¥2,409.980 million.」

    Equity in earnings of affiliates accounted for using the equity method amounted to ¥2,409.980 million, up from ¥1,936.039 million in the previous fiscal year.
  13. FY2023-Q3Third-quarter increase in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 1,395,615 2,059,730」

    Equity in earnings of affiliates accounted for using the equity method for the third quarter of the cumulative consolidated period amounted to ¥2,059.730 million, up from ¥1,395.615 million in the same period of the previous year.
  14. FY2023-Q2Second-quarter increase in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 799,852 1,177,698」

    Equity in earnings of affiliates accounted for using the equity method for the second quarter of the cumulative consolidated period amounted to ¥1,177.698 million, up from ¥799.852 million in the same period of the previous year.
  15. FY2023-Q1First-quarter increase in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 381,507 449,956」

    Equity in earnings of affiliates accounted for using the equity method for the first quarter of the cumulative consolidated period amounted to ¥449.956 million, up from ¥381.507 million in the same period of the previous year.
  16. FY2022Increase in full-year equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method amounted to ¥1,936.039 million.」

    Equity in earnings of affiliates accounted for using the equity method amounted to ¥1,936.039 million, up from ¥1,540.068 million in the previous fiscal year.
  17. FY2022-Q3Third-quarter increase in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 1,179,553 1,395,615」

    Equity in earnings of affiliates accounted for using the equity method for the third quarter of the cumulative consolidated period amounted to ¥1,395.615 million, up from ¥1,179.553 million in the same period of the previous year.
  18. FY2022-Q2Second-quarter increase in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 755,448 799,852」

    Equity in earnings of affiliates accounted for using the equity method for the second quarter of the cumulative consolidated period amounted to ¥799.852 million, up from ¥755.448 million in the same period of the previous year.
  19. FY2022-Q1First-quarter decrease in equity-method investment incomeAnnual report

    「Equity in earnings of affiliates accounted for using the equity method 381,507」

    Equity in earnings of affiliates accounted for using the equity method for the first quarter of the cumulative consolidated period amounted to ¥381.507 million, down from ¥388.027 million in the same period of the previous year.
  20. FY2021Increase in full-year equity-method investment incomeAnnual report

    「Equity-method investment income was ¥1,540,068 thousand.」

    Equity in earnings of affiliates accounted for using the equity method amounted to ¥1,540.068 million, up from ¥1,324.993 million in the previous fiscal year. The strong performance of the Korean affiliate SK Tri Chem is also cited as a factor behind the increase in ordinary income.
  21. FY2021-Q3Increase in equity-method investment income in the third quarterAnnual report

    「Equity-method investment income 945,967 1,179,553」

    Equity-method investment income for the nine-month period was ¥1,179,553 thousand, up from ¥945,967 thousand in the same period of the previous year.
  22. FY2021-Q2Increase in equity-method investment income in the second quarterAnnual report

    「Equity-method investment income 604,948 755,448」

    Equity-method investment income for the six-month period was ¥755,448 thousand, up from ¥604,948 thousand in the same period of the previous year.
  23. FY2021-Q1Increase in equity-method investment income in the first quarterAnnual report

    「Equity-method investment income 309,192 388,027」

    Equity-method investment income was ¥388,027 thousand for the first-quarter cumulative period, up from ¥309,192 thousand in the same period of the previous year.
  24. FY2020Increase in full-year equity-method investment incomeAnnual report

    「Ordinary income was ¥3,744,290 thousand, up 27.7% year on year, due in part to equity-method investment income.」

    Equity-method investment income increased to ¥1,324,993 thousand from ¥826,688 thousand in the previous fiscal year. The strong performance of the South Korean joint venture SK Tri Chem was also cited as a factor behind the results exceeding the plan.
  25. FY2020-Q3Increase in equity-method investment income in the third quarterAnnual report

    「Equity-method investment income 945,967」

    Equity-method investment income for the nine-month period was ¥945,967 thousand, up from ¥492,517 thousand in the same period of the previous year.
  26. FY2020-Q2Increase in equity-method investment income in the second quarterAnnual report

    「Equity-method investment income 604,948」

    Equity-method investment income for the six-month period was ¥604,948 thousand, up from ¥122,648 thousand in the same period of the previous year.
  27. FY2020-Q1Increase in equity-method investment income in the first quarterAnnual report

    「Equity-method investment income 309,192」

    The Group recorded equity-method investment income of ¥309,192 thousand for the first-quarter cumulative period, up from ¥12,118 thousand in the same period of the previous year.
  28. FY2019Full-year equity-method investment profit recordedAnnual report

    「Non-operating income was ¥855,450 thousand, reflecting a contribution of ¥826,688 thousand from equity-method investment income.」

    The Group recorded full-year equity-method investment income of ¥826,688 thousand from the South Korean joint venture and other investees. The stronger-than-expected performance of SK Tri Chem Co., Ltd. was also cited as a factor behind the results exceeding the plan.
  29. FY2019-Q3Increase in share of profit of investments accounted for using the equity methodAnnual report

    「Non-operating income Equity-method investment income 492,517」

    The Group recorded equity-method investment income of ¥492,517 thousand for the nine-month period. This was an increase in the cumulative amount from ¥122,648 thousand for the six-month period.
  30. FY2019-Q2RestatedAnnual report

    「Ordinary income was ¥1,155,355 thousand, due in part to the recognition of equity-method investment income」

    As in the previous quarter, the Group recorded investment income from equity-method investees, including the South Korean joint venture. Equity-method investment income for the six-month period was ¥122,648 thousand.
  31. FY2019-Q1Shift to equity-method investment gainAnnual report

    「Non-operating income Equity-method investment income 12,118」

    The figure changed from the equity-method investment loss disclosed for the previous fiscal year to equity-method investment income of ¥12,118 thousand recorded in the first quarter. Associates including the South Korean joint venture are treated as equity-method investees.
  32. FY2018RestatedAnnual report

    「Investment loss if the equity method were applied (△) (¥ thousands): △108,193」

    For investments in associates, including the South Korean joint venture, the Group disclosed a full-year equity-method investment loss of ¥108,193 thousand. It also recorded ¥565,646 thousand in investment expenditure for the acquisition of shares in an affiliated company.
  33. FY2018-Q3First statedAnnual report

    「Amount of investments in affiliates: ¥867,937 thousand; amount of investments if the equity method were applied: ¥768,650 thousand; amount of equity-method investment loss (△): △¥88,269 thousand」

    The disclosure reports investments in affiliates, including the South Korean joint venture, and an equity-method investment loss of ¥88,269 thousand for the cumulative third quarter under review.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Tri Chemical Laboratories yet. It last moved in the Revision of earnings forecasts of 2026-08-31: "Cited as achieved".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Increase in Investments in Affiliates and Equity-Method Investment Losses | Tri Chemical Laboratories Inc. (4369) | Komori